High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection
Open Access
- 5 June 2021
- Vol. 11 (6), 527
- https://doi.org/10.3390/life11060527
Abstract
Immune reconstitution inflammatory syndrome (IRIS) is an exacerbated immune response that can occur to HIV+ patients after initiating antiretroviral therapy (ART). IRIS pathogenesis is unclear, but dysfunctional and exhausted cells have been reported in IRIS patients, and the TIM-3/Gal-9 axis has been associated with chronic phases of viral infection. This study aimed to evaluate the soluble levels of TIM-3 and Gal-9 and their relationship with IRIS development. TIM-3, Gal-9, TNF-α, IFN-γ, IL-6, TNFR1, TNFR2, E-cadherin, ADAM10, and ADAM17 were measured to search for IRIS-associated biomarkers in plasma samples from 0-, 4-, 8-, 12-, and 24-weeks after ART initiation of 61 HIV+ patients (15 patients developed IRIS, and 46 did not). We found that patients who developed IRIS had higher levels of TIM-3 [median 4806, IQR: 3206–6182] at the time of the IRIS events, compared to any other follow-up time evaluated in these patients or compared with a control group of patients who did not develop IRIS. Similarly, IRIS patients had a higher TNF-α level [median 10.89, IQR: 8.36–12.34] at IRIS events than any other follow-up time evaluated. Other molecules related to the TIM-3 and TNF-α pathway (Gal-9, IL-6, IFN-γ, TNFR1, TNFR2, ADAM-10, and ADAM-17) did not change during the IRIS events. In conclusion, our data suggest that a high level of soluble TIM-3 and TNF-α could be used as an IRIS biomarker.Keywords
This publication has 28 references indexed in Scilit:
- Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infectionPLOS ONE, 2018
- Rapid Decrease of Plasma Galectin-9 Levels in Patients with Acute HIV Infection after TherapyThe Tohoku Journal of Experimental Medicine, 2012
- Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndromeBlood, 2010
- Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesisCurrent Opinion in HIV and AIDS, 2010
- Risk factors for immune reconstitution inflammatory syndrome under combination antiretroviral therapy can be aetiology-specificInternational Journal of STD & AIDS, 2010
- Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4 + and CD8 + T CellsJournal of Virology, 2009
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsThe Lancet Infectious Diseases, 2008
- Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective studyAIDS, 2008
- Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapyAIDS, 2005
- Treatment for Adult HIV InfectionPublished by American Medical Association (AMA) ,2004